The Relationship between Intra-Operative Transfusions and Nadir Hematocrit on Post-Operative Outcomes after Cardiac Surgery.

Uncertainty exists regarding the optimal strategy for the management of anemia in the setting of cardiac surgery. We sought to improve our understanding of the role of intra-operative hematocrit (HCT) and transfusions on peri-operative outcomes following cardiac surgery. A total of 18,886 patients undergoing on-pump cardiac surgery were identified from a multi-institutional registry including surgical and perfusion data. Patients were divided into four groups based on their intra-operative nadir HCT (<21 or ≥21) and whether or not they received intra-operative red blood cell (+RBC or −RBC) transfusions. Outcomes were adjusted for the Society of Thoracic Surgeons predicted risk of mortality (PROM), pre-operative HCT, and medical center. Regardless of nadir HCT cohort, those who received a transfusion had higher PROM relative to patients who did not receive a transfusion. The mean PROM was significantly higher among those HCT ≥21 + RBC (5.3%) vs. HCT ≥ 21 − RBC (1.9%), p < .001. Similarly, the PROM was significantly higher among HCT <21 + RBC (5.1%) vs. those HCT <21 − RBC (3.1%), p < .001. Adjusted outcomes demonstrated an increased impact of RBC transfusions on adverse outcomes irrespective of nadir HCT including stroke (p < .001), renal failure (p < .001), prolonged ventilation (p < .001), and mortality (p < .001). This study demonstrates that transfusions have a more profound effect on postoperative cardiac surgery outcomes than anemia.

[1]  T. Sundt,et al.  Greater Volume of Acute Normovolemic Hemodilution May Aid in Reducing Blood Transfusions After Cardiac Surgery. , 2015, The Annals of thoracic surgery.

[2]  R. Habib,et al.  The independent effects of anemia and transfusion on mortality after coronary artery bypass. , 2014, The Annals of thoracic surgery.

[3]  E. Blackstone,et al.  The least of 3 evils: exposure to red blood cell transfusion, anemia, or both? , 2013, The Journal of thoracic and cardiovascular surgery.

[4]  D. Likosky,et al.  Rationalising the treatment of anaemia in cardiac surgery: short and mid-term results from a local quality improvement initiative , 2010, Quality and Safety in Health Care.

[5]  C. Bodian,et al.  The impact of blood conservation on outcomes in cardiac surgery: is it safe and effective? , 2010, The Annals of thoracic surgery.

[6]  Sean M. O'Brien,et al.  The Society of Thoracic Surgeons 2008 cardiac surgery risk models: part 2--isolated valve surgery. , 2009, The Annals of thoracic surgery.

[7]  Sean M. O'Brien,et al.  The Society of Thoracic Surgeons 2008 cardiac surgery risk models: part 1--coronary artery bypass grafting surgery. , 2009, The Annals of thoracic surgery.

[8]  R. Groom,et al.  Intraoperative Red Blood Cell Transfusion During Coronary Artery Bypass Graft Surgery Increases the Risk of Postoperative Low-Output Heart Failure , 2006, Circulation.

[9]  F. Loop,et al.  Persistent effect of red cell transfusion on health-related quality of life after cardiac surgery. , 2006, The Annals of thoracic surgery.

[10]  Liang Li,et al.  Morbidity and mortality risk associated with red blood cell and blood-component transfusion in isolated coronary artery bypass grafting* , 2006, Critical care medicine.

[11]  M. Borger,et al.  Low hematocrit during cardiopulmonary bypass is associated with increased risk of perioperative stroke in cardiac surgery. , 2005, The Annals of thoracic surgery.

[12]  R. Habib,et al.  Role of hemodilutional anemia and transfusion during cardiopulmonary bypass in renal injury after coronary revascularization: Implications on operative outcome* , 2005, Critical care medicine.

[13]  M. Swaminathan,et al.  The association of lowest hematocrit during cardiopulmonary bypass with acute renal injury after coronary artery bypass surgery. , 2003, The Annals of thoracic surgery.

[14]  R. Habib,et al.  Adverse effects of low hematocrit during cardiopulmonary bypass in the adult: should current practice be changed? , 2003, The Journal of thoracic and cardiovascular surgery.

[15]  R. Groom,et al.  Size makes a difference: use of a low-prime cardiopulmonary bypass circuit and autologous priming in small adults , 2000, Perfusion.

[16]  Howard K. Song,et al.  Update to The Society of Thoracic Surgeons and the Society of Cardiovascular Anesthesiologists Blood Conservation Clinical Practice Guidelines , 2011 .

[17]  Sean M. O'Brien,et al.  The Society of Thoracic Surgeons 2008 cardiac surgery risk models: part 3--valve plus coronary artery bypass grafting surgery. , 2009, The Annals of thoracic surgery.